VIDEOS ICFSR 2019

All videos of the ICFSR 2019 presentations are now online and available to registered ICFSR 2019 attendees.

 

Open access

BIOMARKER AND BIOLOGY OF FRAILTY

 Jeremy Walston (USA)

SARCOPENIA: THE NEW INTERNATIONAL DEFINITION

 John Morley (USA) - Alfonso-Jose Cruz-Jentoft (Spain) - Jurgen M Bauer (Germany)

INTRINSIC CAPACITY

 Matteo Cesari (Italy)

BIOMARKERS OF SARCOPENIA IN VERY OLD PATIENTS WITH HIP FRACTURE

 Alfonso-Jose Cruz-Jentoft (Spain)

ICOPE: INTEGRATED CARE FOR OLDER PEOPLE: PRESENTATION

 Islene Araujo de Carvalho (Switzerland)

EFFECT OF OMEGA-3 FATTY ACID INTAKE ON RED BLOOD CELL FATTY ACID COMPOSITION AND ASSOCIATION WITH INFLAMMATION AND MOBILITY

 Roger Fielding (USA)

THE OPTIMUM PROTEINE INTAKE FOR OLDER ADULTS: SHOULD THE CURRENT RDAs FOR PROTEINE INTAKE BE REVISED?

 Shalender Bhasin (USA)

Reserved access

IMPROVING MUCLE BONE AND MOBILITY IN OLDER AGE

 Debra L. Waters (New Zealand)

ROLE OF MALNUTRITION IN THE DEVELOPMENT OF FRAILTY AND COST IMPLICATIONS AMONG COMMUNITY-DWELLERS

 Suela Sulo (Spain)

FRAILTY AND SARCOPENIA IN LATIN AMERICA. PRESENT AND FUTURE

 Clemente Zuniga-Gil (Mexico)

DEVELOPING THE FIRST TIME INJURIOUS FALLS SCREENING TOOL

 Stina Ek (Sweden)

SYMPO AMAZENTIS - TRANSLATING UROLITHIN A BENEFITSON MUSCLE MITOCHONDRIA INTO HUMANS

 Anurag Singh (Switzerland)

DEVELOPMENTS IN THE PATHOPHYSIOLOGIC BASIS IN FRAILTY: METABOLISM AND THE EMERGING ROLE OF APELIN

 Cedric Dray (France)

IS PRE-OPERATIVE FRAILTY ASSOCIATED WITH WORSE OUTCOMES AFTER TOTAL JOINT REMPLACEMENT

 Lisa A Mandl (USA)

MUCLE MASS ASSESSED BY D3Cr DILUTION AND INCIDENT DISABILITY IN OLDER MEN

 Peggy M Cawthon (USA)

DIFFERENCES IN AMINO ACID COMPOSITION BETWEEN VARIOUS TYPES OF PROTEINES SUPPLEMENTS

 Nathaniel Johnson (USA)

ALLOGENEIC BONE MARROW-DERIVED MESENCHYMAL STEM CELLS AS A TREATMENT FOR AGING RELATED INDICATIONS

 Joshua Hare (USA)

SARCOPENIA BIOMARKERS

 William Evans (USA)

MITOCHONDRIAL FUNCTION AND AGING

 Garth Nicholson (USA)

OVERCOMING THE AGED NICHE TO RESTORE MUCLE FUNCTION

 Adelaida Palla (USA)

DIETARY SUPPLEMENTATION WITH FISH OIL AND CURCUMIN IMPROVES GAIT SPEED AND MITOCHONDRIAL FUNCTION DURING AGING

 Claire Boutry-Regard (Switzerland)

AGING-ASSOCIATED LOSS OF HYPOXIA SIGNALING LIMITS SKELETAL MUSCLE REGENERATION

 Indranil Sinha (USA)

COMPARAISON OF HIGH-INTENSITY INTERVAL TRAINING AND MODERATE-INTENSITY CONTINUOUS TRAINING ON PHYSICAL AND FUNCTIONAL CAPACITIES IN OBESE OLDER ADULTS

 Mylene Aubertin-Leheudre (Canada)

CHANGE IN METABOLIC AND INFLAMMATORY BIOMARKERS AFTER A 24-WEEK MULTIMODAL INTERVENTION DESIGNED TO IMPROVE FUNCTIONAL STATUS IN HYPERTENSIVE OLDER ADULTS: A PILOT RANDOMIZED CONTROLLED TRIAL

 Liliana C. Baptista (USA)

OLDER ADULTS WITH BOTH COGNITIVE AND PHYSICAL IMPAIRMENTS ARE AT HIGHEST RISK TO DEVELOP DEMENTIA: A 12-YEAR LONG POPULATION-BASED STUDY ORAL

 Giulia Grande (Sweden)

ASSOCIATION BETWEEN NUTRIENT INTAKE, PHYSICAL ACTIVITY AND SARCOPENIA-RELATED GENE-PROMOTOR DNA METHYLATION

 Lingxiao He (Belgium)

USING SOCIALLY ASSISTIVE ROBOTS FOR MONITORING AND PREVENTING PHYSICAL FRAILTY AMONG OLDER ADULTS: A STUDY ON USABILITY AND USER EXPERIENCE CHALLENGES

 Susanna Del Signore (Italy)

EFFECT OF LOSARTAN AND FISH OIL ON SECONDARY OUTCOMES IN THE ENRGISE PILOT RANDOMIZED CLINICAL TRIAL

 Jane A. Cauley (USA)

THE BURDEN OF AUTONOMOUS LIVING AND BASIC SELF-CARE DISABILITY FOR AGING ADULTS IN THE UNITED STATES: DISABILITY-ADJUSTED LIFE YEARS

 Ryan McGrath (USA)

MULTICENTER COHORT STUDY OF FRAILTY AND ACCESS TO KIDNEY TRANSPLANTATION

 Mara McAdams-DeMarco (USA)

FRAILTY STATUS AFFECTS T CELL RESPONSES TO CMV, BUT NOT THE LEVEL OF CMV DNA

 Nicholas Rodin (USA)

NETWORK ANALYSIS OF FRAILTY AND AGING: EMPIRICAL DATA FROM THE MEXICAN HEALTH AND AGING STUDY

 Luis Miguel Gutierrez-Robledo (Mexico)

NORMATIVE DATA FOR AND PREDICTORS OF 5-YEAR CHANGE IN GAIT SPEED AMONG U.S. OLDER ADULTS IN THE NATIONAL SOCIAL LIFE, HEALTH AND AGING STUDY

 Megane Huisingh-Scheetz (USA)

SARCOPENIC OBESITY IN ASIAN POPULATIONS: INFLUENCE OF OBESITY DEFINITIONS ON PREVALENCE AND PHYSICAL PERFORMANCE

 Ezra Qi-En Khor(Singapore)

UREMIC MYOPATHY: DYNAPENIA, DIABESITY-ASSOCIATED SARCOPENIA & PHYSICAL FRAILTY IN DISGUISE?

 David R. Sinacore (USA)

EFFECT OF GASTRIC ACID SUPPRESSANTS ON RESPONSE TO A PHYSICAL ACTIVITY INTERVENTION AND MAJOR MOBILITY DISABILITY IN OLDER ADULTS: RESULTS FROM THE LIFESTYLE INTERVENTIONS FOR ELDERS (LIFE) STUDY

 Joshua Brown (USA)

INTERVENTIONS TO TREAT FRAILTY: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

 Ahmed Negm (Canada)

INHIBITION OF KYNURENINE PRODUCTION PROTECTS SKELETAL MUSCLE FROM THE AGE-RELATED LOSS OF MASS AND STRENGTH.

 Helen Kaiser (USA)

EARLY KIDNEY DYSFUNCTION IS ASSOCIATED WITH LONGITUDINAL DECLINE IN PHYSICAL PERFORMANCE IN THE ELDERLY

 Joshua I Barzilay (USA)

EVALUATING THE PHYSIOTYPE OF FRAILTY: VALIDATION OF A MEASURE OF PHYSIOLOGICAL MULTISYSTEM DYSREGULATION IN TWO DATASETS

 Alden Gross (USA)

DEFINITION FOR SARCOPENIA: THE SECOND EUROPEAN WORKING GROUP ON SARCOPENIA IN OLDER PEOPLE

 Alfonso-Jose Cruz-Jentoft (Spain)

SYMPO SPRINTT: BIOMARKER AND STUDY: RATIONALE AND METHODS

 Emanuelle Marzetti (italy

SYMPO SPRINTT: PHARMACOLOGICAL AND NUTRACEUTICAL APPROACHES TO SARCOPENIA

 Daniel Rooks (USA)

SYMPO SPRINTT: SARCOPENIA & PHYSICAL FRAILTY IN OLDER PEOPLE: MULTI-COMPONENT TREATMENT STRATEGIES

 Roberto Bernabei (Italy) - Francesco Landi (Italy)

SYMPO BIOPHYTIS: TARGETING THE PROTECTIVE ARM OF RENIN ANGIOTENSIN SYSTEM FOR DRUG DEVELOPMENT IN AGE RELATED SARCOPENIA

 Marco Pahor(USA) - Stanislas Veillet (France) - Waly Dioh (France)

SYMPO LONGEVERON: TRENDS IN ANTI-AGING RESEARCH AIMED AT EXTENDING THE HEALTHSPAN

 Linda P. Fried (USA) - Pinchas Cohen(USA) - Joshua M. Hare (USA)

U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS) INITIATIVES TO IMPROVE FUNCTION, PROMOTE HEALTHY AGING AND INDEPENDENT LIVING AMONG OLDER ADULTS

 Marie A. Bernard(USA) - Rosaly Correa-de-Araujo (USA) - Carol Nohelia Montoya (USA)